CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $227,000 | -14.0% | 5,000 | 0.0% | 0.15% | -11.5% |
| Q1 2018 | $264,000 | -22.4% | 5,000 | 0.0% | 0.17% | -12.6% |
| Q4 2017 | $340,000 | -17.5% | 5,000 | 0.0% | 0.20% | -6.6% |
| Q3 2017 | $412,000 | -37.1% | 5,000 | -28.6% | 0.21% | -38.6% |
| Q2 2017 | $655,000 | +2.8% | 7,000 | -30.0% | 0.35% | -2.0% |
| Q1 2017 | $637,000 | – | 10,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |